NET LOSS PER SHARE

9 Months Ended

Dec. 31, 2022

Basic and diluted net income (loss) per share attributable to common stockholders was calculated as follows:


	Three Months Ended December 31,				Nine Months Ended December 31,
	2022		2021		2022		2021
Numerator:


Net income (loss) attributable to common stockholders—basic and diluted	$	(21,270)	$	(13,241)	$	(47,317)	$	(31,589)
Denominator:
Weighted average common shares outstanding—basic and diluted	177,672,036		172,554,101		176,546,378		150,313,932




Net income (loss) per share attributable to common stockholders
Net income (loss) per share attributable to common stockholders - basic and diluted	$	(0.12)	$	(0.08)	$	(0.27)	$	(0.21)

For the three and nine months ended December 31, 2022 , the Company’s potential dilutive securities, which include stock options, RSUs, warrants and convertible notes have been excluded from the computation of diluted net loss per share as the effect would be to reduce the net loss per share. Therefore, the weighted-average number of

shares of common stock outstanding used to calculate both basic and diluted net loss per share attributable to common stockholders is the same for the three and nine months ended December 31, 2022 .

For the three and nine months ended December 31, 2021, the Company’s potential dilutive securities, which include redeemable convertible preferred stock, stock options and warrants, have been excluded from the computation of diluted net loss per share as the effect would be to reduce the net loss per share. Therefore, the weighted-average number of shares of common stock outstanding used to calculate both basic and diluted net loss per share attributable to common stockholders is the same for the three and nine months ended December 31, 2021.

The Company excluded the following potential shares of common stock, presented based on amounts outstanding at December 31, 2022 and 2021 from the computation of diluted net loss per share attributable to common shareholders for the three and nine months ended December 31, 2022 and 2021 because including them would have had an anti-dilutive effect.


	As of
	December 31,
		2022	2021
Stock options to purchase common stock		16,068,852	23,902,292
Restricted stock units		8,615,450	1,979,396
Warrants to purchase common stock		13,036,333	13,036,333
2025 Convertible Notes as converted to common stock		8,390,774	7,952,919

The Company also had convertible notes outstanding for the three and nine months ended December 31, 2022, which could have obligated the Company and/or its stockholders to issue shares of common stock upon the occurrence of various future events at prices and in amounts that are not determinable until the occurrence of those future events. Because the necessary conditions for the conversion of these instruments had not been satisfied during the three and nine months ended December 31, 2022, the Company excluded these instruments from the table above and the calculation of diluted net loss per share for the period. See Note 5, “Debt,” for additional details.